Wei Zhang, MD, PhD
Beijing Tiantan Hospital · Tang-Du Hospital · Duke University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wei Zhang, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:06 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07873996 · Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed GlioblastomaBeijing Tiantan Hospital · not yet recruiting · Newly Diagnosed Glioblastoma, IDH-wildtype · principal investigator
- N/ANCT07682428 · Exploration of the Association Between White Matter Lesion Burden and Dalfampridine Response in Insidious-Onset Vascular ParkinsonismTang-Du Hospital · completed · Vascular Parkinsonism · principal investigator
- Ph3NCT04504396 · Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin MonotherapyPegBio Co., Ltd. · completed · Type 2 Diabetes Mellitus (T2DM)
- Ph2NCT00331799 · Pilot Study of Duloxetine in Psychological ResilienceDuke University · completed · Major Depressive Disorder · principal investigator
- Ph2/Ph3NCT00299611 · Augmentation Study of Levetiracetam in Obsessive Compulsive DisorderDuke University · terminated · Obsessive-Compulsive Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.